Page results
-
This page has been written for patients who are having radioactive iodine (131I) ablation and/or radioiodine treatment for thyroid cancer.
-
The National Paediatric Diabetes Audit (NPDA) is asking all children and young people (8-19 years) and parents/carers (of children under 8 years old) who have received diabetes care in the past 6 months, to fill in the survey.
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
-
This page is for patients with obesity who are waiting for scheduled surgery.
-
How UCLH uses clinical data in research.
-
Information for service users about the RESPOND service for refugees and asylum seekers.
-
Fears that people with high blood pressure are more at risk from severe Covid-19 because it is easier for the virus to enter their cells and tissues have been laid to rest, thanks to research involving UCLH.
-
A new CAR T-cell therapy developed by scientists at UCL has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase 1 clinical trial of patients at UCLH.
-
One of our patients who is recovering from COVID-19 has been appearing across national media as she recounts her story and thanks the staff who saved her life.
-
This information explains brain stem death and the tests used to confirm the diagnosis. It aims to answer frequently asked questions.
File results
-
FOI/2023/0081 - Biometric technology wearables/ data collection
-
FOI/2023/0082 - Organisation structure for Performance and Planning department
-
FOI/2023/0083 - Software systems/ suppliers used at Trust
-
FOI/2023/0086 - Number/ wait times for MRI scans for multiple sclerosis/ dementia/ prostate/ pancreatic cancer
-
FOI/2021/0284 - Sleep respiratory service
-
FOI/2023/0099 - Number of autoclaves used at Trust
-
FOI/2023/0101 - Trauma protocols in pregnant patients
-
FOI/2023/0103 - Genetic Haemochromatosis patients
-
FOI/2023/0105 - Maternity services birthing centre
-
FOI/2023/0109 - UK-EU aggrement S2 funding applications and treatments